Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment Group.
about
Avoiding hepatic metastasis naturally: Lessons from the cotton top tamarin (Saguinus oedipus)Role of surgery in colorectal cancer liver metastasesMultisciplinary management of patients with liver metastasis from colorectal cancerUnresolved issues and controversies surrounding the management of colorectal cancer liver metastasisBiochemical Parameters for Longitudinal Monitoring of Liver Function in Rat Models of Partial Hepatectomy Following Liver InjuryDefining patient outcomes in stage IV colorectal cancer: a prospective study with baseline stratification according to disease resectability statusMaximum Diameter and Number of Tumors as a New Prognostic Indicator of Colorectal Liver MetastasesMultidisciplinary approach of colorectal cancer liver metastases.Histopathologic factors affecting tumor recurrence after hepatic resection in colorectal liver metastasesPredictors and prognosticators for survival with Yttrium-90 radioembolization therapy for unresectable colorectal cancer liver metastasisFOXFIRE protocol: an open-label, randomised, phase III trial of 5-fluorouracil, oxaliplatin and folinic acid (OxMdG) with or without interventional Selective Internal Radiation Therapy (SIRT) as first-line treatment for patients with unresectable liA systematic review of treatment guidelines for metastatic colorectal cancerMetastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.The role of peri-operative treatment in resectable liver metastases of colorectal cancer.Consensus report of the 4th International Forum for Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid Magnetic Resonance ImagingAn update on chemotherapy of colorectal liver metastasesSinusoidal obstruction syndrome (SOS) related to chemotherapy for colorectal liver metastases: factors predictive of severe SOS lesions and protective effect of bevacizumab.Phase II study of helical tomotherapy in the multidisciplinary treatment of oligometastatic colorectal cancerChemotherapy plus targeted drugs in conversion therapy for potentially resectable colorectal liver metastases: a meta-analysis.Efficacy and safety of bevacizumab plus chemotherapy compared to chemotherapy alone in previously untreated advanced or metastatic colorectal cancer: a systematic review and meta-analysis.The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus.Stereotactic body radiotherapy (SBRT) with or without surgery for primary and metastatic liver tumorsAssessment of Tumor Response and Resection Rates in Unresectable Colorectal Liver Metastases Following Neoadjuvant Chemotherapy with CetuximabTargeted therapies in colorectal cancer: surgical considerations.Clinical practice guidelines for the management of metastatic colorectal cancer: a consensus statement of the Hellenic Society of Medical Oncologists (HeSMO).Yttrium-90 radioembolization as salvage therapy for colorectal cancer with liver metastases.Hepatic artery infusion with raltitrexed or 5-fluorouracil for colorectal cancer liver metastasis.Prognostic factors for transarterial chemoembolization combined with sustained oxaliplatin-based hepatic arterial infusion chemotherapy of colorectal cancer liver metastasis.Role of cetuximab in first-line treatment of metastatic colorectal cancerRole of surgery in colorectal liver metastases: too early or too late?Use of clinical score to stage and predict outcome of hepatic resection of metastatic colorectal cancer.Biologic modulation of chemotherapy in patients with hepatic colorectal metastases: the role of anti-VEGF and anti-EGFR antibodies.Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease.Bevacizumab for metastatic colorectal cancer: a NICE single technology appraisal.Challenges in the modification of the M1 stage of the TNM staging system for nasopharyngeal carcinoma: A study of 1027 cases and review of the literature.Impact of cetuximab in current treatment of metastatic colorectal cancer.Surgical margin size in hepatic resections for colorectal metastasis: impact on recurrence and survival.How to expand the safe limits in hepatic resections?Locoregional therapies for metastatic colorectal carcinoma to the liver--an evidence-based review.Liver-directed treatments for metastatic colorectal cancer.
P2860
Q26746925-DE04023B-CFA0-4E92-A954-43E5040DAD97Q26830444-65032809-947C-4911-990A-B0F45D789E4AQ28069575-9AB43D23-D108-4409-B080-A622382DB484Q28085651-0559EE45-24A0-4F03-9EB8-C992440510C6Q28534113-7AC7D755-2614-435D-80EC-9BF338464E8BQ33630882-B8831086-CACA-4A0D-AEB1-5618161B3F41Q33770802-AF641DD9-885D-40FA-B031-D8FE6C192633Q33779859-E828BFEF-891D-40B3-B324-AF812A84576BQ33879785-F0E71DE6-0015-4824-BF2B-25CC139D5BEFQ33914190-3682C288-163E-43D9-9351-4E8D008DD03AQ33938461-654D0474-D06C-4989-A0F5-9C69FAC3EB11Q33995028-6DC51119-6771-42D6-9753-780929D83416Q34664272-2A4C79D9-6121-4797-A8F2-A4B667550F47Q35076305-A7EA9721-AFF2-451E-A1C0-ABA3E93DFE1DQ35148664-B0AC5B03-094F-4C27-9EC0-2005C86260DEQ35653578-9DC6A326-9EB8-4D15-AEB0-9EFBABBD1BB6Q35854745-C4156F89-C7A3-4DE4-BA27-6B03C211CFB2Q35968430-692B3113-D2F2-43AC-B150-B8E3CA91D492Q36036077-223A3382-6CC5-44B1-9E72-AC00B31A5152Q36112303-BF161606-CB5D-4843-A2AB-CA0DC29E8A63Q36349575-A746D382-0B0D-4B7D-A2AE-7B789579E496Q36570322-ACCFDF22-0441-4A16-8A22-F7C087E75782Q36739940-BCCA36D0-B7BC-4B43-9F24-C3725D97FE00Q37015697-3260D641-BC73-4176-B48F-579F92920AA3Q37308725-DC0CB95F-EC00-4EE7-B987-4A259E2ECA16Q37339616-70ABFBA1-95AD-42B1-895A-5C4205CD46ADQ37672223-9205F25A-29F7-4A1F-87FC-26E1D637E401Q37697312-F81A869B-DD34-489A-B4FC-0831C260D1E4Q37708010-5B447EC3-02A5-426D-AE34-27F680D13C1CQ37774980-59630FBF-6262-4B5F-9804-A12BA371CAE2Q37821840-F8ED49BC-3BB1-4F80-AB09-809BF117D165Q37821843-FBEB783D-6BFD-4BD5-98E4-0A6AFB4DF10BQ37858449-E61065A9-AE7F-486F-AFE8-FEDA716D622CQ38051449-1BCD32AF-E076-4926-81C4-FA1161DC631EQ38058790-E9F96783-3B72-4455-951B-94A985A904B3Q38183447-30C54E6B-E8A0-491B-AA55-4877353A06BBQ38186578-4E52EDE6-186A-49C3-A966-045A44251D68Q38188520-C23757FB-07E4-4601-A923-88BA373BD826Q38206730-A4610A52-FC4D-4CA5-B0DA-21ECF7A0B6F6Q38222125-48A061ED-567A-4D5F-8A91-0F63535F6622
P2860
Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment Group.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Does chemotherapy prior to liv ...... al Metastases Treatment Group.
@en
type
label
Does chemotherapy prior to liv ...... al Metastases Treatment Group.
@en
prefLabel
Does chemotherapy prior to liv ...... al Metastases Treatment Group.
@en
P2093
P50
P921
P1476
Does chemotherapy prior to liv ...... al Metastases Treatment Group.
@en
P2093
Alberto Sobrero
Alfredo Carrato
Bernard Nordlinger
Dag Arvidsson
European Colorectal Metastases Treatment Group
Felice Giuliante
Graeme Poston
Harpreet Wasan
Marc Ychou
Markus Golling
P304
P356
10.1016/J.EJCA.2007.07.017
P577
2007-09-04T00:00:00Z